摘要 |
<p>The present invention disclose a new polypeptide-human L1 factor ORF2 reverse transcription-related protein 13, the polynucleotide encoding it and a method producing the polypeptide by recombinant DNA technology. The present invention further disclose a method using the polynucleotide to treat various disorders, e.g. malignant neoplasm, hematopathy, developmental disorder, HIV infection and immunological disease and various inflammation etc. The present invention also disclose an antagonist of the polypeptide and its therapeutic use. The present invention further disclose the use of the polynucleotide encoding the new human L1 factor ORF2 reverse transcription-related protein 13.</p> |